IFIT2 and pulmonary arterial hypertension: IFIT2 has been identified as a potential biomarker of ischemic cardiomyopathy in human and rat heart tissue samples [58], and it has been found to be highly expressed in HF patients with pulmonary arterial hypertension [59].